Live Analyst Rating Changes 2120 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Allen Lutz
BofA
Allen Lutz
Bank of America Securities
Wall Street Analyst
★★★☆☆
#1543
on 13Foresight · ranked by our own returns
50%
Success Rate
-4.8%
Average Return
13 of 26 calls profitable · -8.2% vs benchmark
🔒 5-year track record is Pro. Showing 1-year — upgrade.
📈 Across the calls we could measure, roughly 50% of Allen Lutz's ratings turned a profit when each position was held for 1 year — averaging -4.8% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

116 Buy 46 Hold 42 Sell
Allen's Stock Coverage 22 ratings · 2026-06-24
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return
GRDN
Guardian Pharmacy Services, Inc. Class A
 Jun 23, 2026 BUY Strong Buy
+4.9% avg upside
7 analysts
 — ·
CVS
CVS Health
 Jun 22, 2026 BUY Strong Buy
+0.3% avg upside
38 analysts
$110.00
8.29% Upside
 +0.3%
OMCL
Omnicell
 Jun 11, 2026 BUY Strong Buy
+37.9% avg upside
12 analysts
$70.00
82.29% Upside
 ·
XRAY
DENTSPLY SIRONA
 Jun 11, 2026 BUY Buy
+174.8% avg upside
25 analysts
$17.00
66.76% Upside
 +0.6%
MCK
McKesson
 Jun 08, 2026 BUY Strong Buy
-3.8% avg upside
27 analysts
$900.00
17.75% Upside
 -0.4%
DOCS
Doximity
 Jun 05, 2026 BUY Buy
+61.1% avg upside
27 analysts
$38.00
85.54% Upside
 +0.4%
PGNY
Progyny
 Jun 02, 2026 BUY Strong Buy
+10.9% avg upside
14 analysts
$31.00
16.47% Upside
 +3.2%
HQY
Healthequity
 May 29, 2026 BUY Strong Buy
+33.6% avg upside
20 analysts
$125.00
47.11% Upside
 -2.4%
HIMS
Hims & Hers Health
 May 28, 2026 HOLD Buy
-23.4% avg upside
22 analysts
$25.00
24.12% Downside
 +7.0%
TDOC
Teladoc
 May 28, 2026 BUY Buy
+276.2% avg upside
37 analysts
$9.00
17.07% Upside
 -5.6%
COR
Cencora
 May 27, 2026 HOLD Buy
+11.4% avg upside
43 analysts
$280.00
0.39% Downside
 +3.8%
HSIC
Henry Schein
 May 14, 2026 BUY Buy
+7.4% avg upside
25 analysts
 — +10.3%
NVST
Envista Holdings
 May 14, 2026 BUY Buy
+15.0% avg upside
19 analysts
$34.00
34.69% Upside
 -2.7%
CAH
Cardinal Health
 May 13, 2026 BUY Strong Buy
-14.7% avg upside
29 analysts
$240.00
4.91% Upside
 +20.6%
WAY
Waystar Holding Corp.
 Apr 30, 2026 BUY Strong Buy
+108.4% avg upside
29 analysts
 — -13.9%
DH
Definitive Healthcare Corp
 Apr 13, 2026 BUY Hold
+676.2% avg upside
19 analysts
$3.50
374.86% Upside
 -23.4%
ACH
Accendra Health
 Mar 31, 2026 SELL Hold
+452.6% avg upside
17 analysts
$2.25
28.04% Downside
 ·
GDRX
GoodRx Holdings
 Feb 26, 2026 SELL Buy
+387.5% avg upside
28 analysts
$1.90
28.75% Downside
 -31.2%
AMWL
American Well
 Aug 05, 2024 HOLD Hold
+67.8% avg upside
15 analysts
 — -11.3%
SONX
Sonendo
 Nov 09, 2023 BUY Buy
+1874.9% avg upside
5 analysts
$0.85
41.59% Upside
 ·
OWLT
Owlet
 Jun 20, 2023 HOLD Strong Buy
+125.8% avg upside
10 analysts
$11.90
125.41% Upside
 -9.7%
BBLNF
Babylon Holdings
 Aug 10, 2022 HOLD Buy
+65549900.1% avg upside
6 analysts
$41.25
41249900.06% Upside
 ·
🔒 17 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Allen Lutz — Frequently Asked Questions
How accurate are Allen Lutz's stock ratings?
Based on the calls 13Foresight could measure, about 50% of Allen's ratings were profitable over a one-year hold, with an average return of -4.8% per rating, or -8.2% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Allen ranked on 13Foresight?
Allen Lutz is currently ranked #1543 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Allen cover?
Allen most recently has ratings on GRDN, CVS, OMCL, XRAY, MCK, DOCS, PGNY, HQY, HIMS, TDOC, COR, HSIC and 10 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.